Company page

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. is a public company traded under the ticker PPCB in the American market. With a market capitalization of approximately $3.35 million, the company focuses on developing innovative treatments for cancer. Propanc aims to advance its proprietary therapies to improve patient outcomes and address unmet medical needs in oncology.